These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 25884918)

  • 1. Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients.
    Pistelli M; De Lisa M; Ballatore Z; Caramanti M; Pagliacci A; Battelli N; Ridolfi F; Santoni M; Maccaroni E; Bracci R; Santinelli A; Biscotti T; Berardi R; Cascinu S
    BMC Cancer; 2015 Mar; 15():195. PubMed ID: 25884918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer.
    Hong J; Mao Y; Chen X; Zhu L; He J; Chen W; Li Y; Lin L; Fei X; Shen K
    Tumour Biol; 2016 Mar; 37(3):4135-42. PubMed ID: 26490984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients.
    Bozkurt O; Karaca H; Berk V; Inanc M; Ocak Duran A; Ozaslan E; Ucar M; Ozkan M
    J BUON; 2015; 20(6):1432-9. PubMed ID: 26854438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased neutrophil-lymphocyte ratio independently predicts poor survival in non-metastatic triple-negative breast cancer patients.
    Qiu X; Song Y; Cui Y; Liu Y
    IUBMB Life; 2018 Jun; 70(6):529-535. PubMed ID: 29707892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
    Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
    PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.
    de Nonneville A; Gonçalves A; Zemmour C; Cohen M; Classe JM; Reyal F; Colombo PE; Jouve E; Giard S; Barranger E; Sabatier R; Bertucci F; Boher JM; Houvenaeghel G
    Eur J Cancer; 2017 Oct; 84():34-43. PubMed ID: 28780480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer.
    Patel DA; Xi J; Luo J; Hassan B; Thomas S; Ma CX; Campian JL
    Breast Cancer Res Treat; 2019 Apr; 174(2):443-452. PubMed ID: 30604000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.
    Chen Y; Chen K; Xiao X; Nie Y; Qu S; Gong C; Su F; Song E
    BMC Cancer; 2016 May; 16():320. PubMed ID: 27198767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
    Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
    J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer.
    de la Cruz-Ku G; Chambergo-Michilot D; Torres-Roman JS; Rebaza P; Pinto J; Araujo J; Morante Z; Enriquez D; Flores C; Luque R; Saavedra A; Lujan M; Gomez H; Valcarcel B
    PLoS One; 2020; 15(12):e0243447. PubMed ID: 33284847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-treatment neutrophil to lymphocyte ratio is a predictor of prognosis in endometrial cancer.
    Haruma T; Nakamura K; Nishida T; Ogawa C; Kusumoto T; Seki N; Hiramatsu Y
    Anticancer Res; 2015 Jan; 35(1):337-43. PubMed ID: 25550569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.
    Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L
    J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma.
    Zhang L; Wang R; Chen W; Xu X; Dong S; Fan H; Liu C
    HPB (Oxford); 2016 Jul; 18(7):600-7. PubMed ID: 27346141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer.
    He J; Lv P; Yang X; Chen Y; Liu C; Qiu X
    Tumour Biol; 2016 Jul; 37(7):9037-43. PubMed ID: 26762408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database.
    Chen QX; Li JJ; Wang XX; Lin PY; Zhang J; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(4):6206-6215. PubMed ID: 28008158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
    Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
    Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
    Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
    World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.
    Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Tumour Biol; 2016 Jan; 37(1):361-8. PubMed ID: 26219894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
    He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
    Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
    Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
    J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.